How This Evidence Evolved
Esophagectomy Surgical Approach
From Open Transthoracic to Minimally Invasive and Robotic Esophagectomy
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Follow-up studies, subgroup analyses, and real-world validation
Integration into clinical practice guidelines and recommendations
Current standard of care and ongoing research directions
Landmark Trials in This Story
Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
Pulmonary infection by 2 weeks: MIE 9% vs open 29% (RR 0.30; 95% CI 0.12–0.76; p=0.005)
Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer
Major complications (Clavien-Dindo ≥II) — hybrid MIE 36% vs open 64% (p<0.001); pulmonary complications 18% vs 30%
Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial
Surgery-related postoperative complications: RAMIE 59% vs open 80% (RR 0.74, 95% CI 0.57-0.96, p=0.02)
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.